Showing results (231-240 of 282) with videos related to

Sort By:
Pageof 29
Nature Reviews. Clinical Oncology|February 26, 2021
Immunogenicity of CAR T cells in cancer therapyDimitrios L Wagner, Enrico Fritsche, Michael A Pulsipher, et al.
Blood|October 7, 2017
Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemiaAlan S Wayne, Nirali N Shah, Deepa Bhojwani, et al.
Blood|April 7, 2006
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome predictionCarla S Wilson, George S Davidson, Shawn B Martin, et al.
The Journal of Allergy and Clinical Immunology|December 14, 2011
Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiencyChimene Kesserwan, Robert Sokolic, Edward W Cowen, et al.
JAMA Oncology|November 12, 2020
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical TrialEhab Atallah, Charles A Schiffer, Jerald P Radich, et al.
Ejhaem|December 18, 2024
Proteogenomic characterization of highly enriched viable leukemic blasts in acute myeloid leukemia: A SWOG reportJasmine Naru, Megan Othus, ChenWei Lin, et al.
Cancers|September 12, 2017
The PI3Kδ Inhibitor Idelalisib Inhibits Homing in an in Vitro and in Vivo Model of B ALLEtai Adam, Hye Na Kim, Eun Ji Gang, et al.
Blood|August 30, 2011
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOGPhoenix A Ho, Kenneth J Kopecky, Todd A Alonzo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignanciesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Blood Advances|August 12, 2024
Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALLColleen Annesley, Adam Lamble, Corinne Summers, et al.
Pageof 29